$887 Million is the total value of SPHERA FUNDS MANAGEMENT LTD.'s 100 reported holdings in Q4 2018. The portfolio turnover from Q3 2018 to Q4 2018 was - .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| CELG | New | CELGENE CORP | $29,802,000 | – | 465,000 | +100.0% | 3.36% | – |
| AZN | New | ASTRAZENECA PLCsponsored adr | $19,560,000 | – | 515,000 | +100.0% | 2.20% | – |
| PANW | New | PALO ALTO NETWORKS INC | $17,514,000 | – | 24,885 | +100.0% | 1.97% | – |
| ITRN | New | ITURAN LOCATION AND CONTROL | $14,637,000 | – | 122,177 | +100.0% | 1.65% | – |
| AXGT | New | AXOVANT SCIENCES LTD | $8,167,000 | – | 8,200,000 | +100.0% | 0.92% | – |
| GWPH | New | GW PHARMACEUTICALS PLCads | $7,499,000 | – | 77,000 | +100.0% | 0.84% | – |
| OSMT | New | OSMOTICA PHARMACEUTICALS PLC | $7,147,000 | – | 922,200 | +100.0% | 0.81% | – |
| GBT | New | GLOBAL BLOOD THERAPEUTICS IN | $6,034,000 | – | 147,000 | +100.0% | 0.68% | – |
| ORTX | New | ORCHARD THERAPEUTICS PLCads | $5,820,000 | – | 370,000 | +100.0% | 0.66% | – |
| MHK | New | MOHAWK INDS INC | $4,659,000 | – | 10,661 | +100.0% | 0.52% | – |
| LOGC | New | LOGICBIO THERAPEUTICS INC | $4,343,000 | – | 417,625 | +100.0% | 0.49% | – |
| RCKT | New | ROCKET PHARMACEUTICALS INC | $4,298,000 | – | 290,001 | +100.0% | 0.48% | – |
| SGMO | New | SANGAMO THERAPEUTICS INC | $3,903,000 | – | 340,000 | +100.0% | 0.44% | – |
| KRYS | New | KRYSTAL BIOTECH INC | $3,629,000 | – | 174,625 | +100.0% | 0.41% | – |
| XBI | New | SPDR SERIES TRUSTs&p biotech | $3,228,000 | – | 45,000 | +100.0% | 0.36% | – |
| AGIO | New | AGIOS PHARMACEUTICALS INC | $3,112,000 | – | 67,500 | +100.0% | 0.35% | – |
| ALLO | New | ALLOGENE THERAPEUTICS INC | $3,055,000 | – | 113,437 | +100.0% | 0.34% | – |
| SAGE | New | SAGE THERAPEUTICS INCput | $2,347,000 | – | 24,500 | +100.0% | 0.26% | – |
| KRNT | New | KORNIT DIGITAL LTD | $2,122,000 | – | 30,342 | +100.0% | 0.24% | – |
| ARYA | New | ARYA SCIENCES ACQUISITION CO | $2,048,000 | – | 200,000 | +100.0% | 0.23% | – |
| IDRA | New | IDERA PHARMACEUTICALS INC | $1,234,000 | – | 445,558 | +100.0% | 0.14% | – |
| MGTX | New | MEIRAGTX HOLDINGS PLC | $686,000 | – | 71,159 | +100.0% | 0.08% | – |
| SBPH | New | SPRING BK PHARMACEUTICALS IN | $530,000 | – | 51,015 | +100.0% | 0.06% | – |
| CNST | New | CONSTELLATION PHARMCETICLS I | $281,000 | – | 70,162 | +100.0% | 0.03% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2019-02-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| TEVA PHARMACEUTICAL-SP ADR | 36 | Q3 2023 | 8.4% |
| MERCK & CO INC NEW | 35 | Q3 2023 | 8.4% |
| NICE Systems Ltd | 27 | Q3 2023 | 4.4% |
| BIOGEN INC | 26 | Q3 2023 | 6.7% |
| AMICUS THERAPEUTICS INC | 26 | Q2 2022 | 4.3% |
| PFIZER INC | 25 | Q3 2023 | 9.2% |
| SAREPTA THERAPEUTICS INC | 25 | Q3 2023 | 3.2% |
| JOHNSON & JOHNSON | 24 | Q3 2023 | 8.0% |
| UNIQURE NV | 23 | Q3 2023 | 1.2% |
| SYNDAX PHARMACEUTICALS INC | 22 | Q3 2023 | 3.9% |
View SPHERA FUNDS MANAGEMENT LTD.'s complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Cyclacel Pharmaceuticals, Inc. | February 06, 2023 | 250,000 | 2.0% |
| Altimmune, Inc. | February 14, 2022 | 1,244,241 | 3.1% |
| Allot Ltd. | February 16, 2021 | 1,129,054 | 3.2% |
| Larimar Therapeutics, Inc. | February 16, 2021 | ? | ? |
| Neos Therapeutics, Inc. | February 16, 2021 | ? | ? |
| Orgenesis Inc. | February 16, 2021 | 525,216 | 0.0% |
| Sio Gene Therapies Inc. | February 16, 2021 | ? | ? |
| X4 Pharmaceuticals, Inc | February 16, 2021 | 250,000 | 0.0% |
| Axovant Gene Therapies Ltd. | February 25, 2020 | 2,931,017 | 8.0% |
| Axovant Gene Therapies Ltd. | February 11, 2020 | 398,540 | 1.8% |
View SPHERA FUNDS MANAGEMENT LTD.'s complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-15 |
| 13F-HR/A | 2024-02-15 |
| 13F-HR | 2024-02-14 |
| SC 13G | 2024-02-08 |
| SC 13G/A | 2024-02-05 |
| SC 13G/A | 2024-02-05 |
| SC 13G/A | 2024-02-05 |
| SC 13G/A | 2024-02-05 |
| 13F-HR | 2023-11-14 |
| SC 13G | 2023-10-10 |
View SPHERA FUNDS MANAGEMENT LTD.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.